Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H2N2O3 |
| Molecular Weight | 114.0596 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1NC(=O)C(=O)N1
InChI
InChIKey=ZFLIKDUSUDBGCD-UHFFFAOYSA-N
InChI=1S/C3H2N2O3/c6-1-2(7)5-3(8)4-1/h(H2,4,5,6,7,8)
| Molecular Formula | C3H2N2O3 |
| Molecular Weight | 114.0596 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Computational thermochemistry of six ureas, imidazolidin-2-one, N,N'-trimethyleneurea, benzimidazolinone, parabanic acid, barbital (5,5'-diethylbarbituric acid), and 3,4,4'-trichlorocarbanilide, with an extension to related compounds. | 2010-09-02 |
|
| Phenotype microarray profiling of Zymomonas mobilis ZM4. | 2010-05 |
|
| The vibrational spectrum of parabanic acid by inelastic neutron scattering spectroscopy and simulation by solid-state DFT. | 2010-03-18 |
|
| Formamide as the main building block in the origin of nucleic acids. | 2007-08-16 |
|
| Origin of informational polymers: The concurrent roles of formamide and phosphates. | 2006-11 |
|
| Study on reactions of 2-(dinitromethylene)-4,5-imidazolidinedione. | 2004-06-25 |
|
| Peroxynitrite reacts with 8-nitropurines to yield 8-oxopurines. | 2002-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:52:10 GMT 2025
by
admin
on
Mon Mar 31 20:52:10 GMT 2025
|
| Record UNII |
3XGR439T9P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID2059516
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | |||
|
67126
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | |||
|
m8396
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
C005411
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | |||
|
204-434-3
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | |||
|
74661
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | |||
|
3XGR439T9P
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | |||
|
9789
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY | |||
|
120-89-8
Created by
admin on Mon Mar 31 20:52:10 GMT 2025 , Edited by admin on Mon Mar 31 20:52:10 GMT 2025
|
PRIMARY |